Evidence map›Paper›PMID 35499604›Full record

ArticleLifetime data analysis2022

Privacy-preserving estimation of an optimal individualized treatment rule: a case study in maximizing time to severe depression-related outcomes.

Erica E M Moodie, Janie Coulombe, Coraline Danieli, Christel Renoux, Susan M Shortreed

Abstract read
In one paragraph

Article in Lifetime data analysis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Erica E M MoodieDepartment of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, QC, Canada. erica.moodie@mcgill.ca.ORCID 0000-0002-7225-3977
Janie CoulombeDepartment of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, QC, Canada.
Coraline DanieliDepartment of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, QC, Canada.
Christel RenouxDepartment of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, QC, Canada.
Susan M ShortreedBiostatistics Unit, Kaiser Permanente Washington Health Research Institute, Seattle, USA.

Funding

Improved tailoring of depression care using customized clinical decision supportR01MH114873 · NIMH · KAISER FOUNDATION RESEARCH INSTITUTE · PI MOODIE, ERICA, SHORTREED, SUSAN M · 2018 to 2021
$1.5M
NIMH NIH HHS R01 MH114873
6 · The paper itself

Abstract

Estimating individualized treatment rules-particularly in the context of right-censored outcomes-is challenging because the treatment effect heterogeneity of interest is often small, thus difficult to detect. While this motivates the use of very large datasets such as those from multiple health systems or centres, data privacy may be of concern with participating data centres reluctant to share individual-level data. In this case study on the treatment of depression, we demonstrate an application of distributed regression for privacy protection used in combination with dynamic weighted survival modelling (DWSurv) to estimate an optimal individualized treatment rule whilst obscuring individual-level data. In simulations, we demonstrate the flexibility of this approach to address local treatment practices that may affect confounding, and show that DWSurv retains its double robustness even when performed through a (weighted) distributed regression approach. The work is motivated by, and illustrated with, an analysis of treatment for unipolar depression using the United Kingdom's Clinical Practice Research Datalink.

Indexed as

ConfidentialityDepressionPrecision MedicineHumansPatient AcuityTreatment OutcomeData aggregationDistributed regressionDynamic weighted survival modellingEffect modificationPrecision medicineSelective serotonin reuptake inhibitors

Identifiers

PMID35499604
PMCPMC10805063

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.